SCHEMBL4762162

SCHEMBL4762162

CC(C)CC(NC(=O)OC(C)(C)C)C(=O)N(C(=O)Nc1ccccc1)C1CCCNC[C@@H]1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
REN P00797 3/20 0.38
PSEN1 P49768 2/20 0.37
PSEN2 P49810 2/20 0.37
APH1B Q8WW43 2/20 0.37
NCSTN Q92542 2/20 0.37
APH1A Q96BI3 2/20 0.37
PSENEN Q9NZ42 2/20 0.37
CTSL P07711 3/20 0.37
CTSB P07858 2/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 2/20 0.37
ACE P12821 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766632 0.88 NPC1 (0.41) MAPK1KMT2AMEN1CTSSCTSK
SCHEMBL6593215 0.85 MAPK1 (0.36) MAPK1KMT2AMEN1MAPTREN
SCHEMBL6588445 0.83 MAPK1 (0.38) MAPK1KMT2AMEN1MAPTREN
SCHEMBL5971691 0.78 MAPK1 (0.36) MAPK1KMT2AMEN1MAPTREN
SCHEMBL6611358 0.78 MAPK1 (0.36) MAPK1MAPTRENPSEN1PSEN2
SCHEMBL4766735 0.77 CTSK (0.38) MAPK1RENCTSLCTSBCTSS
SCHEMBL4762159 0.77 MAP1LC3B (0.41) MAPK1KMT2AMEN1MAPTREN
SCHEMBL6214945 0.77 MAPK1 (0.44) MAPK1KMT2ARENPSEN1PSEN2
SCHEMBL4212772 0.77 CTSS (0.35) MAPK1KMT2AMEN1CTSLCTSB
SCHEMBL3955653 0.76 CTSL (0.36) MAPK1CTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO disclosed